Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.82 EUR | 0.00% | +1.87% | -24.46% |
03-27 | Icape: 20% drop in annual net income | CF |
03-27 | Icape Holding S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 11.35 for the current year.
- The stock, which is currently worth 2024 to 0.49 times its sales, is clearly overvalued in comparison with peers.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Semiconductors
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-24.46% | 85.54M | - | ||
+81.49% | 2,212B | B- | ||
+35.24% | 641B | A- | ||
+3.06% | 246B | B- | ||
+25.89% | 203B | B- | ||
+9.73% | 170B | A- | ||
+42.07% | 134B | B+ | ||
-40.60% | 127B | C+ | ||
+44.84% | 112B | - | - | |
+4.35% | 103B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ALICA Stock
- Ratings Icape Holding